Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System.
Tomasetti C, Montemitro C, Fiengo ALC, Santone C, Orsolini L, Valchera A, Carano A, Pompili M, Serafini G, Perna G, Vellante F, Martinotti G, Giannantonio MD, Kim YK, Nicola MD, Bellomo A, Ventriglio A, Fornaro M, Berardis DD. Tomasetti C, et al. Among authors: fiengo alc. Curr Pharm Des. 2019;25(4):381-387. doi: 10.2174/1381612825666190312102444. Curr Pharm Des. 2019. PMID: 30864501 Review.
New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Vellante F, Fornaro M, Fiengo A, Mazza M, Vecchiotti R, Perna G, de Bartolomeis A, Martinotti G, Di Giannantonio M, De Berardis D. Orsolini L, et al. Among authors: fiengo a. Expert Rev Neurother. 2016 May;16(5):483-95. doi: 10.1586/14737175.2016.1173545. Epub 2016 Apr 18. Expert Rev Neurother. 2016. PMID: 27050932 Review.
Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine.
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo ALC, Martinotti G, Vellante F, Matarazzo I, Vecchiotti R, Perna G, Di Nicola M, Carano A, Di Bartolomeis A, De Giannantonio M, De Berardis D. Orsolini L, et al. Among authors: fiengo alc. CNS Neurol Disord Drug Targets. 2017;16(1):65-92. doi: 10.2174/1871527315666161025140111. CNS Neurol Disord Drug Targets. 2017. PMID: 27781949 Review.
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors.
De Berardis D, Fornaro M, Valchera A, Cavuto M, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Fiengo A, Ventriglio A, Yong-Ku K, Martinotti G, Di Giannantonio M, Tomasetti C. De Berardis D, et al. Among authors: fiengo a. Int J Mol Sci. 2018 Sep 23;19(10):2888. doi: 10.3390/ijms19102888. Int J Mol Sci. 2018. PMID: 30249029 Free PMC article. Review.
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions.
Tomasetti C, Iasevoli F, Buonaguro EF, De Berardis D, Fornaro M, Fiengo AL, Martinotti G, Orsolini L, Valchera A, Di Giannantonio M, de Bartolomeis A. Tomasetti C, et al. Among authors: fiengo al. Int J Mol Sci. 2017 Jan 12;18(1):135. doi: 10.3390/ijms18010135. Int J Mol Sci. 2017. PMID: 28085108 Free PMC article. Review.